임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 1상모집 예정· Recurrent Diffuse Large B-Cell LymphomaLymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
협력: 노바티스
- 1상모집 예정· Large-cell LymphomaCAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
협력: 노바티스
- 1상모집 중· Breast NeoplasmsA Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers
리드: 노바티스
- 1상모집 예정· Elevated Blood PressureHJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
리드: 노바티스
- 1상모집 중· Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
리드: 노바티스
- 1상모집 중· Breast CancerStudy of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
리드: 노바티스
- 1상모집 중· Advanced HR+/HER2- Breast CancerStudy of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
리드: 노바티스
- 1상모집 중· Metastatic Castration-resistant Prostate Cancer (mCRPC)A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
리드: 노바티스
- 1상모집 중· Advanced Malignancies and Hepatic ImpairmentPharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment
리드: 노바티스
- 1상모집 중· Primary Myelofibrosis (PMF)Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
리드: 노바티스
- 1상모집 중· Heart Failure With Reduced Ejection FractionA Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
리드: 노바티스
- 1상모집 중· Metastatic Prostate Cancer177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
협력: 노바티스
- 1상모집 중· Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaAsciminib Maintenance Therapy Following alloHCT or CAR T to Prevent Relapse in Adults With Ph+ALL
협력: 노바티스
- 1상모집 중단 (진행 중)· Metastatic Prostate Cancer (mCRPC)A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer
리드: 노바티스
- 1상모집 중· Pancreatic Ductal AdenocarcinomaPhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
리드: 노바티스
- 1상모집 중· Chronic Kidney DiseaseSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
리드: 노바티스
- 1상모집 중· Small Cell Lung CarcinomaPhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
리드: 노바티스
- 1상모집 중· Charcot-Marie-Tooth Disease, Type 1AA First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.
리드: 노바티스
- 1상모집 중· Metastatic Castrate Resistant Prostate Cancer (mCRPC)Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)
협력: 노바티스
- 1상모집 중단 (진행 중)· Rheumatoid ArthritisAn Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
리드: 노바티스
- 1상모집 중· Metastatic Castration-Resistant Prostate CancerA Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
리드: 노바티스
- 1상모집 중· Pancreatic Ductal AdenocarcinomaPhase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
리드: 노바티스
- 1상모집 중단 (진행 중)· Systemic Lupus Erythematosus, SLEAn Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
리드: 노바티스
- 1상모집 중단 (진행 중)· Metastatic Neuroendocrine Prostate CancerNEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerLuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
협력: 노바티스
- 1상모집 중단 (진행 중)· Newly Diagnosed and Recurrent GlioblastomaDose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
리드: 노바티스
- 1상모집 중단 (진행 중)· Sickle Cell DiseaseLong-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
리드: 노바티스
- 1상모집 중· Recurrent Ovarian CancerCPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
협력: 노바티스
- 1상모집 중단 (진행 중)· Mycosis FungoidesTulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
협력: 노바티스
- 1상모집 중단 (진행 중)· Breast Cancer[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerPhase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
리드: 노바티스
- 1상모집 중단 (진행 중)· MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.
리드: 노바티스
- 1상모집 중단 (진행 중)· Myeloid DiseasesDose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
리드: 노바티스
- 1상모집 중단 (진행 중)· Alzheimer DiseaseStudy of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
리드: 노바티스
- 1상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
리드: 노바티스
- 1상모집 중단 (진행 중)· B-cell Non-Hodgkin Lymphoma (B-NHL)Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies
리드: 노바티스
- 1상모집 중· Metastatic Breast CancerPhase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
협력: 노바티스, 화이자
- 1상모집 중· Metastatic MelanomaNilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
협력: 노바티스
- 1상모집 중단 (진행 중)· Breast CancerAlpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
협력: 길리어드, 노바티스
- 1상모집 중단 (진행 중)· MesotheliomaA Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerA Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer
협력: 노바티스
- 1상모집 중· Metastatic Breast CancerRibociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
협력: 노바티스
- 1상모집 중· Gastroenteropancreatic Neuroendocrine TumorStudy of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery
협력: 노바티스
- 1상모집 중· Recurrent World Health Organization (WHO) Grade II GliomaTrametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
협력: 노바티스
- 1상모집 중단 (진행 중)· Glioblastoma MultiformeTrial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
협력: 노바티스
- 1상모집 중단 (진행 중)· Advanced Solid TumorsRollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
리드: 노바티스
- 1상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungStudy of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.
리드: 노바티스
- 1상모집 중단 (진행 중)· Acute Lymphoblastic Leukemia ALLRibociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
협력: 노바티스
- 1상모집 중· B-cell Acute Lymphoblastic LeukemiaABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
협력: 노바티스
- 1상모집 중단 (진행 중)· Multiple MyelomaUp-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma
협력: 노바티스
- 1상모집 중단 (진행 중)· EGFR-mutant Non-small Cell Lung CancerStudy of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
리드: 노바티스
- 1상모집 중단 (진행 중)· Multiple MyelomaA Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.